Sarepta Therapeutics, Inc. 4
4 · Sarepta Therapeutics, Inc. · Filed Sep 2, 2016
Insider Transaction Report
Form 4
Aphale Jayant
SVP Technical Operations
Transactions
- Tax Payment
Common Stock
2016-08-31$26.07/sh−765$19,944→ 11,490 total
Footnotes (1)
- [F1]Shares withheld by the Company to satisfy tax withholding obligations related to the vesting of restricted stock granted to executive in lieu of a portion of the executive's annual cash bonus on February 29, 2016 and reported on the executive's Form 4 filed on March 2, 2016.